147 related articles for article (PubMed ID: 27233268)
41. Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.
Hawman DW; Fox JM; Ashbrook AW; May NA; Schroeder KMS; Torres RM; Crowe JE; Dermody TS; Diamond MS; Morrison TE
Cell Rep; 2016 Aug; 16(5):1326-1338. PubMed ID: 27452455
[TBL] [Abstract][Full Text] [Related]
42. Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research.
Kumar S; Mamidi P; Kumar A; Basantray I; Bramha U; Dixit A; Maiti PK; Singh S; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
Arch Virol; 2015 Nov; 160(11):2749-61. PubMed ID: 26280524
[TBL] [Abstract][Full Text] [Related]
43. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.
Warter L; Lee CY; Thiagarajan R; Grandadam M; Lebecque S; Lin RT; Bertin-Maghit S; Ng LF; Abastado JP; Desprès P; Wang CI; Nardin A
J Immunol; 2011 Mar; 186(5):3258-64. PubMed ID: 21278338
[TBL] [Abstract][Full Text] [Related]
44. Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M.
Theillet G; Martinez J; Steinbrugger C; Lavillette D; Coutard B; Papageorgiou N; Dalbon P; Leparc-Goffart I; Bedin F
Virology; 2019 Mar; 529():195-204. PubMed ID: 30721816
[TBL] [Abstract][Full Text] [Related]
45. High seroprevalence of chikungunya virus antibodies among pregnant women living in an urban area in Benin, West Africa.
Bacci A; Marchi S; Fievet N; Massougbodji A; Perrin RX; Chippaux JP; Sambri V; Landini MP; Varani S; Rossini G
Am J Trop Med Hyg; 2015 Jun; 92(6):1133-6. PubMed ID: 25940198
[TBL] [Abstract][Full Text] [Related]
46. Development of Neutralization Assay Using an eGFP Chikungunya Virus.
Deng CL; Liu SQ; Zhou DG; Xu LL; Li XD; Zhang PT; Li PH; Ye HQ; Wei HP; Yuan ZM; Qin CF; Zhang B
Viruses; 2016 Jun; 8(7):. PubMed ID: 27367716
[TBL] [Abstract][Full Text] [Related]
47. The neutralizing role of IgM during early Chikungunya virus infection.
Chua CL; Sam IC; Chiam CW; Chan YF
PLoS One; 2017; 12(2):e0171989. PubMed ID: 28182795
[TBL] [Abstract][Full Text] [Related]
48. Utilization and Assessment of Throat Swab and Urine Specimens for Diagnosis of Chikungunya Virus Infection.
Raut CG; Hanumaiah H; Raut WC
Methods Mol Biol; 2016; 1426():75-83. PubMed ID: 27233262
[TBL] [Abstract][Full Text] [Related]
49. Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™.
Pedraza-Escalona M; Guzmán-Bringas O; Arrieta-Oliva HI; Gómez-Castellano K; Salinas-Trujano J; Torres-Flores J; Muñoz-Herrera JC; Camacho-Sandoval R; Contreras-Pineda P; Chacón-Salinas R; Pérez-Tapia SM; Almagro JC
BMC Infect Dis; 2021 Oct; 21(1):1121. PubMed ID: 34717584
[TBL] [Abstract][Full Text] [Related]
50. Antiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti Mosquitoes.
Mishra P; Furey C; Balaraman V; Fraser MJ
Viruses; 2016 Jun; 8(6):. PubMed ID: 27294950
[TBL] [Abstract][Full Text] [Related]
51. Detection of Chikungunya Virus in Nepal.
Pandey BD; Neupane B; Pandey K; Tun MM; Morita K
Am J Trop Med Hyg; 2015 Oct; 93(4):697-700. PubMed ID: 26195462
[TBL] [Abstract][Full Text] [Related]
52. Chikungunya virus glycoproteins pseudotype with lentiviral vectors and reveal a broad spectrum of cellular tropism.
Hu D; Zhang J; Wang H; Liu S; Yu L; Sun L; Qu Y
PLoS One; 2014; 9(10):e110893. PubMed ID: 25333782
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of multiple antigenic peptides based on the Chikungunya E2 protein for improved serological diagnosis of infection.
Bhatnagar S; Kumar P; Mohan T; Verma P; Parida MM; Hoti SL; Rao DN
Viral Immunol; 2015 Mar; 28(2):107-12. PubMed ID: 25412351
[TBL] [Abstract][Full Text] [Related]
54. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
Her Z; Teng TS; Tan JJ; Teo TH; Kam YW; Lum FM; Lee WW; Gabriel C; Melchiotti R; Andiappan AK; Lulla V; Lulla A; Win MK; Chow A; Biswas SK; Leo YS; Lecuit M; Merits A; Rénia L; Ng LF
EMBO Mol Med; 2015 Jan; 7(1):24-41. PubMed ID: 25452586
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic accuracy of a rapid E1-antigen test for chikungunya virus infection in a reference setting.
Huits R; Okabayashi T; Cnops L; Barbé B; Van Den Berg R; Bartholomeeusen K; Ariën KK; Jacobs J; Bottieau E; Nakayama EE; Shioda T; Van Esbroeck M
Clin Microbiol Infect; 2018 Jan; 24(1):78-81. PubMed ID: 28606643
[TBL] [Abstract][Full Text] [Related]
56. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
[TBL] [Abstract][Full Text] [Related]
57. Seroprevalence and clinical manifestations of chikungunya virus infection in rural areas of Chandrapur, Maharashtra, India.
Kawle AP; Nayak AR; Bhullar SS; Borkar SR; Patankar SD; Daginawala HF; Singh LR; Kashyap RS
J Vector Borne Dis; 2017; 54(1):35-43. PubMed ID: 28352044
[TBL] [Abstract][Full Text] [Related]
58. Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein.
Bréhin AC; Rubrecht L; Navarro-Sanchez ME; Maréchal V; Frenkiel MP; Lapalud P; Laune D; Sall AA; Desprès P
Virology; 2008 Feb; 371(1):185-95. PubMed ID: 17949772
[TBL] [Abstract][Full Text] [Related]
59. Development of monoclonal antibody based antigen capture ELISA to detect chikungunya virus antigen in mosquitoes.
Hundekar SL; Thakare JP; Gokhale MD; Barde PV; Argade SV; Mourya DT
Indian J Med Res; 2002 Apr; 115():144-8. PubMed ID: 12239836
[TBL] [Abstract][Full Text] [Related]
60. Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.
Fox JM; Diamond MS
J Immunol; 2016 Dec; 197(11):4210-4218. PubMed ID: 27864552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
